...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Pfizer
3
Mar 11, 2024 10:20AM
3
Mar 12, 2024 08:12AM
3
Mar 12, 2024 01:45PM
6
Mar 12, 2024 02:38PM
2
Mar 12, 2024 03:23PM
7
Mar 12, 2024 04:21PM
Share
New Message
Please login to post a reply